<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016708"><a href="http://purl.obolibrary.org/obo/MONDO_0016708">MONDO:0016708</a></h3>
<p><strong>Label:</strong> embryonal tumor of neuroepithelial tissue</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0008380">MONDO:0008380</a> (retinoblastoma), <a href="http://purl.obolibrary.org/obo/MONDO_0020560">MONDO:0020560</a> (atypical teratoid rhabdoid tumor), <a href="http://purl.obolibrary.org/obo/MONDO_0007959">MONDO:0007959</a> (medulloblastoma), <a href="http://purl.obolibrary.org/obo/MONDO_0016713">MONDO:0016713</a> (central nervous system primitive neuroectodermal tumor), <a href="http://purl.obolibrary.org/obo/MONDO_0005072">MONDO:0005072</a> (neuroblastoma), <a href="http://purl.obolibrary.org/obo/MONDO_0016715">MONDO:0016715</a> (ependymoblastoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_790">Orphanet:790</a>, <a href="http://purl.obolibrary.org/obo/OMIM_155255">OMIM:155255</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251858">Orphanet:251858</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616792">OMIM:616792</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251867">Orphanet:251867</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613014">OMIM:613014</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613013">OMIM:613013</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251863">Orphanet:251863</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256700">OMIM:256700</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613016">OMIM:613016</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613015">OMIM:613015</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613017">OMIM:613017</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251870">Orphanet:251870</a>, <a href="http://www.orpha.net/ORDO/Orphanet_251880">Orphanet:251880</a>, <a href="http://www.orpha.net/ORDO/Orphanet_635">Orphanet:635</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99966">Orphanet:99966</a>, <a href="http://www.orpha.net/ORDO/Orphanet_616">Orphanet:616</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609322">OMIM:609322</a>, <a href="http://purl.obolibrary.org/obo/OMIM_180200">OMIM:180200</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument))) 46.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000271">HP:0000271</a> (Abnormality of the face))) 46.41%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100705">HP:0100705</a> (Abnormality of the glial cells))) 43.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0009733">HP:0009733</a> (Glioma))) 43.89%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin))) 43.04%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000315">HP:0000315</a> (Abnormality of the orbital region))) 42.52%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe))) 40.27%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology))) 40.27%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0100886">HP:0100886</a> (Abnormality of globe location))) 39.81%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000316">HP:0000316</a> (Hypertelorism))) 38.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0100836">HP:0100836</a> (Malignant neoplasm of the central nervous system) 37.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004375">HP:0004375</a> (Neoplasm of the nervous system) 33.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0030063">HP:0030063</a> (Neuroepithelial neoplasm) 32.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) and <a href="http://purl.obolibrary.org/obo/HP_0030063">HP:0030063</a> (Neuroepithelial neoplasm) 32.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0030061">HP:0030061</a> (Neuroectodermal neoplasm) 32.62%</li>
</ul>
</body>
</html>
